This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of accessory sinuses (controls excluding all cancers)
C3_ACCESSORY_SINUS_EXALLC
No definition available.
Endpoint definition
↥
FinnGen phenotype data
individuals
Apply sex-specific rule None
Check conditions None
Check pre-conditions, main-only, mode, registry filters
Cause of death: ICD-10
C31
Cause of death: ICD-9
160
Cause of death: ICD-8
160
Cause of death: excluded ICD-9
160[0-1]
Cause of death: excluded ICD-8
160[0-1]
Cancer registry: Topography ICD-O-3
C31
Cancer registry: Morphology ICD-O-3
ANY
Cancer registry: Behaviour codes
3
2 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Include endpoints None
-
Remove individuals based on genotype QC
59
C3_ACCESSORY_SINUS_EXALLC
Control definitions
Control exclude
C3_CANCER, C3_CANCER_WIDE
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9
No upset plot: script not run.
No upset table: script not run.
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of accessory sinuses (controls excluding all cancers)
based on the number of shared cases.
Broader endpoints:
- Malignant neoplasm of accessory sinuses
- Malignant neoplasm of nasal cavity and sinuses
- Malignant neoplasm of nasal cavity and sinuses (controls excluding all cancers)
- Malignant neoplasm of respiratory system and intrathoracic organs
- Malignant neoplasm of respiratory system and intrathoracic organs (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 59 | 22 | 37 |
| Unadjusted prevalence (%) | 0.01 | 0.01 | 0.02 |
| Mean age at first event (years) | 64.37 | 62.01 | 65.77 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_ACCESSORY_SINUS_EXALLC – Malignant neoplasm of accessory sinuses (controls excluding all cancers)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Malignant neoplasm of accessory sinuses (controls excluding all cancers)
↥Endpoint not on priority list, no data to show.